Suchergebnisse - "WOODMAN MICHAEL E"

PubPharm (36)

1

Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754) : A Phase I Randomized Placebo-Controlled Study

enthalten in: Clinical pharmacology and therapeutics | 2024

von Datta-Mannan, A. | Regev, A. | Coutant, D. | +7

2

Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL‐17A( LY3509754) : A Phase I Randomized Placebo‐Controlled Study

enthalten in: Clinical Pharmacology & Therapeutics | 2024

von Datta‐Mannan, A. | Regev, A. | Coutant, D. | +7

3

PAN-ELR+ CXC CHEMOKINE ANTIBODIES FOR THE TREATMENT OF RESPIRATORY DISEASE

enthalten in: Europäisches Patentamt | 2023

von PATEL DIPAK | WITCHER DERRICK R | WOODMAN MICHAEL E

4

호흡기 질환의 치료를 위한 Pan-ELR+ CXC 케모카인 항체

enthalten in: Europäisches Patentamt | 2023

von PATEL DIPAK | WITCHER DERRICK R | WOODMAN MICHAEL E

5

PAN-ELR + CXC chemokine antibodies for treatment of respiratory diseases

enthalten in: Europäisches Patentamt | 2022

von PATEL DHAVAL | WITCHER DERRICK RYAN | WOODMAN MICHAEL E

6

PAN-ELR+ CXC chemokine antibodies for the treatment of respiratory disease

enthalten in: Europäisches Patentamt | 2022

von PATEL DIPAK | WITCHER DERRICK R | WOODMAN MICHAEL E

7

Prediction and analysis of functional RNA structures within the integrative genomics viewer

enthalten in: NAR genomics and bioinformatics | 2022

von Rouse, W. | Andrews, R. | Booher, N. | +5

8

PAN-ELR+ CXC CHEMOKINE ANTIBODIES FOR THE TREATMENT OF RESPIRATORY DISEASE

enthalten in: Europäisches Patentamt | 2021

von PATEL DIPAK | WITCHER DERRICK R | WOODMAN MICHAEL E

9

Utilization of peptide phage display to investigate hotspots on IL-17A and what it means for drug discovery

enthalten in: PloS one | 2018

von Ting, J. | Tung, F. | Antonysamy, S. | +15

10

Direct PCR of Intact Bacteria (Colony PCR)

enthalten in: Current protocols in microbiology | 2016

von Woodman, M. | Savage, C. | Arnold, W. | +1